The Food and Drug Administration approved Eli Lilly’s type 2 diabetes drug tirzepatide for use in chronic weight management, making official the use of a medicine already widely prescribed off-label for weight loss. The drug, called Mounjaro for diabetes, will be called Zepbound for weight loss. (CNN)
The agency has also received at least three reports of people being hospitalized after taking counterfeit versions of the wildly popular weight-loss drugs called semaglutides. At least one of these reports includes mention of a counterfeit version of the Novo Nordisk medication Ozempic.(U.S. News and World Report)
Marijuana and abortion are still at risk in Ohio despite Tuesday night’s election results. Earlier this week, Ohio voters passed a measure to protect access to abortion in the state and legalize recreational marijuana use. (The Columbus Dispatch)
American depositary receipts of Avadel Pharmaceuticals rose 19% on revenue growth powered by sales of Lumryz in the third quarter. The Ireland-based company widened its loss to $36.3 million. (MarketWatch)
A viral TikTok documented the case of a 38-year-old woman who went to the hospital to receive a colectomy, only to wake up to the news that she had stage 3 colon cancer. While she was under anesthesia, doctors had to give her a hysterectomy. (People)
